Letter to Editor: In response to existence of SARS-CoV-2 in the peritoneal fluid
Gustavo Romero-Velez, Guillermo Ponce de Leon-Ballesteros, Juan Barajas-Gamboa, Jerry Dang, Andrew Strong, Mathew Kroh, Orkun Ilgen, Mehmet Eyuphan Ozgozen, Ozgur Appak, Begum Ertan, Hikmet Tunc Tımur, Omer Erbil Dogan, Cemal Posacı

Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCOVID-19 and healthcare impacts · Long-Term Effects of COVID-19 · COVID-19 Clinical Research Studies
We read with great interest the article recently published by Ilgen et al.^(1)^ in which the authors prospectively collected peritoneal samples of patients positive for SARS-CoV-2 undergoing cesarean section. Their study increases the understanding of SARS-CoV-2 and the risk of infection while performing surgery, however, we would like to caution the authors in their conclusion. The authors findings are that none of the eight patients were positive for SARS-CoV-2 in their peritoneal samples and thus conclude that the exposure due to aerosolization of surgical fumes does not seem to be likely. Although the majority of case reports and case series have not been able to identify the presence of SARS-CoV-2 in the peritoneum, our recent systematic review on the topic found that 5.9% of the cases are likely to be positive, which is even higher for patients with severe disease.^(2^the virus responsible for COVID-19, in the abdominal cavity as well as in other abdominal tissues which surgeons are exposed has been investigated in several studies. The aim of the present systematic review was to analyze if the virus can be identify in the abdominal cavity.\nMethods We performed a systematic review to identify relevant studies regarding the presence of SARS-CoV-2 in abdominal tissues or fluids. Number of patients included as well as patient's characteristics, type of procedures, samples and number of positive samples were analyzed.\nResults A total of 36 studies were included (18 case series and 18 case reports) Thus, there is a theoretical risk of exposure to healthcare providers while performing surgery in infected patients. In a similar way, the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) guidelines in the topic recommends protective measures to prevent the exposure in the era of COVID-19.^(3)^ or suspecting of having, the SARS-CoV-2 as well as the healthcare team involved.\nMethods Systematic literature reviews were conducted for 2 key questions (KQ^)^
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Ilgen O Ozgozen ME Appak O Ertan B Tımur HT Dogan OE Existence of SARS-Cov-2 in the peritoneal fluid Rev Bras Ginecol Obstet 202345526126510.1055/s-0043-177012937339645 PMC 10281764 · doi ↗ · pubmed ↗
- 2Romero-Velez G Ponce de Leon-Ballesteros G Al Zubaidi M Barajas-Gamboa JS Dang J Corcelles R Presence of SARS-Co V-2 in abdominal tissues and biologic fluids during abdominal surgery: a systematic review Surg Endosc 20233775011502110.1007/s 00464-023-10130-w 37219799 PMC 10204688 · doi ↗ · pubmed ↗
- 3Collings AT Jeyarajah DR Hanna NM Dort J Tsuda S Nepal P SAGES 2022 guidelines regarding the use of laparoscopy in the era of COVID-19Surg Endosc 20223652723273310.1007/s 00464-022-09133-w 35237900 PMC 8890462 · doi ↗ · pubmed ↗
- 4Romero-Velez G Ponce de Leon-Ballesteros G Al Zubaidi M Barajas-Gamboa JS Dang J Corcelles R Presence of SARS- Co V-2 in abdominal tissues and biologic fluids during abdominal surgery: a systematic review Surg Endosc 20233775011502110.1007/s 00464-023-10130-w 37219799 PMC 10204688 · doi ↗ · pubmed ↗
- 5Fabbri N Pesce A Ussia A D’Urbano F Pizzicotti S Greco S Swab test in biological fluids as predictor of COVID-19 transmission risk during surgery: a prospective cross-sectional study from an Italian COVID center BMC Surg 20222111911910.1186/s 12893-022-01571-635351083 PMC 8964243 · doi ↗ · pubmed ↗
- 6Ilgen O Ozgozen ME Appak O Ertan B Tlmur HT Dogan OE Existence of SARS-Cov-2 in the peritoneal fluid Rev Bras Ginecol Obstet 202345526126510.1055/s-0043-177012937339645 PMC 10281764 · doi ↗ · pubmed ↗
- 7Collings AT Jeyarajah DR Hanna NM Dort J Tsuda S Nepal P SAGES 2022 guidelines regarding the use of laparoscopy in the era of COVID-19Surg Endosc 20223652723273310.1007/s 00464-022-09133-w 35237900 PMC 8890462 · doi ↗ · pubmed ↗
